Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-16

FDA Approved: TERIPARATIDE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s generic teriparatide through an original ANDA for use in osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Teriparatide)

Snippet

ORIG AP for TERIPARATIDE (TERIPARATIDE)